Cirik Mustafa Ozgur, Yenibertiz Derya
Mustafa Ozgur Cirik, Department of Anesthesiology, University of Health Sciences, Ataturk Chest Diseases and Chest Surgery Training and Research Hospital, Ankara, Turkey.
Derya Yenibertiz, Department of Pulmonology, University of Health Sciences, Ataturk Chest Diseases and Chest Surgery Training and Research Hospital, Ankara, Turkey.
Pak J Med Sci. 2021 Jan-Feb;37(1):15-20. doi: 10.12669/pjms.37.1.3189.
We aimed to investigate the prognostic factors related to 30 day mortality of elderly patients with respiratory failure in the intensive care unit (ICU).
We performed a single centre, retrospective study and analyzed the main variables and outcomes of 238 geriatric patients admitted to an ICU with ARF between December 2017- January 2019 in Chest Disease Hospital, were included and classified as survivors and nonsurvivors. Main characteristics, laboratory datas, severity and nutrition scores were evaluated and logistic regression analysis were used.
The nonsurvivor group included 110 cases (40% female,) with a median age of 79, had higher scores in the followings; Acute Physiology Chronic Health Evaluation II score (APACHE-II) (p < 0.001), Charlson Comorbidity Index (CCI) (p < 0.001), Sequential Organ Failure Assessment score (p < 0.001). The inotropic support requirement was also higher in the nonsurvivor group (48,2%). As a comorbidity, malignancy and Type-I respiratory failure were higher in the nonsurvivor group (p=0.03, p < 0.001). The overall 30-day mortality was 46%. Blood urea nitrogen, procalsitonin, C-reactive protein and creatinine levels were higher in the nonsurvivor group (p < 0.001). However, albumin (p < 0.001), BMI (p=0.03) and longer hospital stay (p < 0.001) were higher in the survivor group. Inotropic support, APACHE-II score and CCI were independently related to increased mortality risk, whereas albumin was associated with decreased mortality risk.
High APACHE II score, low CCI, low albumin levels and the requirement for inotropic support were found to be independently risk factors of 30-day mortality in the geriatric patients with respiratory failure in ICU.
我们旨在研究重症监护病房(ICU)中老年呼吸衰竭患者30天死亡率的相关预后因素。
我们进行了一项单中心回顾性研究,分析了2017年12月至2019年1月期间入住胸科医院ICU的238例急性呼吸衰竭(ARF)老年患者的主要变量和结局,并将其分为幸存者和非幸存者。评估了主要特征、实验室数据、严重程度和营养评分,并进行了逻辑回归分析。
非幸存者组包括110例(40%为女性),中位年龄为79岁,在以下方面得分较高;急性生理与慢性健康状况评分系统II(APACHE-II)评分(p<0.001)、查尔森合并症指数(CCI)(p<0.001)、序贯器官衰竭评估评分(p<0.001)。非幸存者组对血管活性药物支持的需求也更高(48.2%)。作为合并症,非幸存者组的恶性肿瘤和I型呼吸衰竭发生率更高(p=0.03,p<0.001)。30天总体死亡率为46%。非幸存者组的血尿素氮、降钙素原、C反应蛋白和肌酐水平较高(p<0.001)。然而,幸存者组的白蛋白水平(p<0.001)、体重指数(BMI)(p=0.03)和住院时间更长(p<0.001)。血管活性药物支持、APACHE-II评分和CCI与死亡风险增加独立相关,而白蛋白与死亡风险降低相关。
高APACHE II评分、低CCI、低白蛋白水平以及对血管活性药物支持的需求是ICU中老年呼吸衰竭患者30天死亡率的独立危险因素。